Zohar Gendler, Managing Partner & CEO
Former CEO and director of Beta-O2 Technologies (a biomedical company which developed proprietary Implantable bio-artificial pancreas), brought the company to one of the world leaders positioning in the area.
Served as CEO of the Technion Entrepreneurial Incubator (TEIC) for a period of 11 years.Led the establishment and investment in 53 companies, such as Prolor Biotech (sold to OPKO, $480M), Mazor Robotics (Sold to Medtronic, $1.6B), ReWalk (NASDAQ: RWLK), Corindus (Sold to Siemens, $1.1B), and many others.
Gained a wide range of experience in identifying new technologies and in establishing, directing, and creating value for technology-based start-up companies.
Served as a member of the Technion’s Patent Committee. (1998 – 2006).
Earned his M.Sc. in material engineering, a B.Sc. in physics, and a certificate in business management, all from the Technion, Israel Institute of Technology.
Nizar Mishael, Managing Partner & CFO
The CFO for all portfolio companies. Nizar manages the finances of these companies with strong leadership, closely following the budget, making sure the companies receive their full government money, and ensuring they set goals and achieve what they should (and when) with their funds. Nizar takes an active role with follow-on funding and handling complex investment transactions. It's with his capabilities that NGT3 and its portfolio companies receive the maximum support possible from the government. Nizar is a certified CPA and holds an MBA from Tel Aviv University’s Recanati program. He joined NGT in 2006.
Livnat Ben-Zur, Chief Business and Technology Officer
Ms. Ben-Zur brings over 20 years of experience in the medical device and healthcare industries, holding executive positions in management, business and marketing, in the United States and in Israel.
Livnat has an extensive knowhow in spearheading global product development projects, and leading global business development efforts in various sectors as well as leading development of complex product portfolios from design & development through clinical and production phases up to commercial launch.
Prior to joining NGT, Livnat was the CEO of Corolabs, a deep-lung inhaled therapies, and prior to that the General Manager of Regentis Biomaterials, a tissue regeneration company.
Livnat served as VP Business Development & Director of Women’s Health Program at Galil Medical, where she spearheaded product development processes related to the breast and gynecology applications, as well as managed the clinical program of these applications. Before that Ms. Ben-Zur served as a Director of Marketing of Medinol Ltd, and as Business director of Medical Technology group of Datamonitor Inc.
She holds MBA in marketing and International Business from Tel Aviv University and Bachelor of Sciences, in Biology from Tel Aviv University.
Tamar Kedar Harris Investor Relations
Joined NGT in 2004 as COO. Tamar has been involved in a number of aspects of managing a portfolio of start-ups, including operations, business development, and investor relations. Tamar brings extensive experience in international relations and networks to the NGT3 team. Tamar received her MBA from the University of Haifa and her BA in economics from Tel Aviv University.
Qamar Salem - Legal Consultant
Began her career at NGT3 in 2018 as in-house attorney of NGT3 and its portfolio companies.
Qamar holds L.L.B in Law and Economics from the University of Haifa. she also started her MBA study in International commercial and business law in University of Tel-Aviv and UC Berkeley.
Lina Totry Ghrayeb, Accounting assistant
Began her career at NGT3 in 2003.
Responsible for the bookkeeping , salaries and portfolio etc. for the managing company.
Lina hold BA in Statistics and Special Education from the Haifa University.
Haya Fahoum Darawshi ,Administrative Manager
Joined NGT3 in 2015, holds BA in Economics and Management from the Max Stern Yezreel Valley College.
Incubating innovative life science
& medical Technologies companies